Biggest News Aggregation in the World
📰 Neuroscience Programs News

Neuroscience Programs News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Neuroscience Programs. Real-time updates on events, politics, business and more.

Athersys to Participate in The Cellular Therapies and Transfusion Medicine in Trauma and Critical Care Conference

Athersys, Inc. , a regenerative medicine company developing MultiStem® cell therapy for critical care indications, announced today their participation in the Cellular Therapeutics in Trauma and... | May 1, 2023
United States Willie Mays Colorado State University Athersys Inc University Of California San Francisco Cellular Therapeutics

Athersys to Participate in The Cellular Therapies and Transfusion Medicine in Trauma and Critical Ca

CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) cell therapy for critical care indications, announced today their participation in the Cellular Therapeutics in Trauma and Critical Care’s (CTTACC) conference, “Cellular Therapies and Tran...
United States Willie Mays Ellen Gurley Athersys Inc University Of California San Francisco Colorado State University

Athersys Reports Second Quarter 2022 Financial Results and Provides Business Update

Corporate restructuring underway and MASTERS-2 clinical trial prioritizedConference call begins at 4:30 p.m. Eastern time todayCLEVELAND--(BUSINESS WIRE)--$ATHX #ARDS--Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three and six months ended June 30, 2022 and provided a business update.S...
United States United Kingdom Ellen Gurley Dan Camardo Kasey Rosado Willie Mays

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

UTHealth in Houston and Athersys Announce Commencement of Patient Enrollment in a Phase 2 Trial Evaluating MultiStem® Cell Therapy in Trauma

News Category Global Banking & Finance Reviews UTHealth in Houston and Athersys Announce Commencement of Patient Enrollment in a Phase 2 Trial Evaluating MultiStem® Cell Therapy in Trauma UTHealth in Houston and Athersys Announce Commencement of Patient Enrollment in a Phase 2 Trial Evaluating MultiStem® Cell Therapy in Trauma The University of Texas Health Science Center at Houston (UTHealth) and Athersys, Inc. (NASDAQ: ATHX) announced today that the first patient has been enrolled in a cli...
Memorial Hermann Hospital United States Texas Medical Center University Of Texas Karen Hunady David Schull

Detailed text transcripts for TV channel - MSNBC - 20150324:05:59:00

School, i was hoping to maybe get my homework done. that was my biggest aspiration and maybe winning a baseball game or two. this is amazing that youve come this far. and the google prize, that comes with some real cash, doesnt it? >> yes. the science award is accompanied by a $50,000 cash prize. >> and i read youre using that to create a company to produce this device. >> right. i started a company last summer to commercialize the device and bring it to the people who need it. >> youll be apply...
Doesn T Baseball Game Google Prize Cash Prize College Next Neuroscience Programs

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science